This CE will provide pharmacists with the knowledge of current hepatitis C treatment guidelines and the pharmacology, adverse reactions, and drug interactions associated with these therapies.
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.
- Identify patients who are at risk of contracting hepatitis C
- Explain the pathophysiology of chronic hepatitis C.
- Describe the pharmacology of the direct acting antivirals used to treat chronic hepatitis C.
- Discuss the most common drug interactions associated with hepatitis C treatments.
Release Date: Nov 15, 2022
Credit Expiration Date: Nov 15, 2025